CynoGen Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
12
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
3
CynoGen General Information
Description
Provider of molecular diagnostics and related laboratory testing services intended to offer personalized diagnostic, prognostic and predictive test results. The company's operations include molecular testing of various cancers, including bladder, prostate, lung, breast and hematological malignancies, enabling pathologists, urologists and oncologists to detect any genomic changes that measures the potential aggressiveness of the disease.
Contact Information
Primary Industry
Laboratory Services (Healthcare)
Acquirer
Primary Office
- 25901 Commercentre Drive
- Lake Forest, CA 92630
- United States
CynoGen Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CynoGen Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
CynoGen Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|